BlackRock Fund Advisors’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $80K | Buy |
81,235
+2,356
| +3% | +$2.32K | ﹤0.01% | 3661 |
|
|
2016
Q3 | $89K | Sell |
78,879
-76
| -0.1% | -$86 | ﹤0.01% | 3645 |
|
|
2016
Q2 | $116K | Buy |
78,955
+19,967
| +34% | +$29.3K | ﹤0.01% | 3629 |
|
|
2016
Q1 | $84K | Sell |
58,988
-4,182
| -7% | -$5.96K | ﹤0.01% | 3702 |
|
|
2015
Q4 | $104K | Buy |
63,170
+3,506
| +6% | +$5.77K | ﹤0.01% | 3720 |
|
|
2015
Q3 | $140K | Sell |
59,664
-1,578
| -3% | -$3.7K | ﹤0.01% | 3611 |
|
|
2015
Q2 | $167K | Sell |
61,242
-460,962
| -88% | -$1.26M | ﹤0.01% | 3590 |
|
|
2015
Q1 | $1.75M | Buy |
522,204
+17,182
| +3% | +$57.5K | ﹤0.01% | 3157 |
|
|
2014
Q4 | $1.75M | Buy |
505,022
+70,024
| +16% | +$243K | ﹤0.01% | 3174 |
|
|
2014
Q3 | $2.19M | Sell |
434,998
-18,414
| -4% | -$92.6K | ﹤0.01% | 3113 |
|
|
2014
Q2 | $6.26M | Buy |
453,412
+392,211
| +641% | +$5.42M | ﹤0.01% | 2704 |
|
|
2014
Q1 | $937K | Buy |
61,201
+14,861
| +32% | +$228K | ﹤0.01% | 3197 |
|
|
2013
Q4 | $374K | Buy |
46,340
+1,940
| +4% | +$15.7K | ﹤0.01% | 3267 |
|
|
2013
Q3 | $443K | Buy |
44,400
+4,239
| +11% | +$42.3K | ﹤0.01% | 3212 |
|
|
2013
Q2 | $171K | Buy |
+40,161
| New | +$171K | ﹤0.01% | 3376 |
|